Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum (Q43691648)

25 November 2017

Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum (English)

1 reference

25 November 2017

0 references

1 reference

1 reference

1 reference

He Y

1

1 reference

25 November 2017

Appel S

series ordinal

2

1 reference

25 November 2017

Le W

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

25 November 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

25 November 2017

909

1 reference

25 November 2017

187-193

1 reference

25 November 2017

1-2

1 reference

Microglial response to 6-hydroxydopamine-induced substantia nigra lesions

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Microglia: Intrinsic immuneffector cell of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Microglia responses in the CNS following sciatic nerve transection in C57BL/Wld(s) and BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Microglia: a sensor for pathological events in the CNS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Cytokines and neuropathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Expression of Ia antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Herpes simplex virus type I infection of the CNS induces major histocompatibility complex antigen expression on rat microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

Neuron-microglia interactions in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902681-6

10.1016/S0006-8993(01)02681-6

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference